Liver Cancer Information Center
Each year in the United States, more than 21,000 people will be diagnosed with primary liver cancer (cancer that began in the liver). To reduce these numbers, researchers continue to explore new approaches to liver cancer prevention.
Progress is also being made in the early detection and treatment of liver cancer. Although long-term survival with liver cancer remains poor, advances in surgery, other liver-directed therapies, and targeted systemic therapies are all contributing to improved outcomes. In addition, advances in supportive care have made liver cancer treatment more tolerable, leading to improved quality of life.
Understanding liver cancer treatment options, the role of different doctors specializing in the treatment of liver cancer, and how and when to access new and innovative liver cancer treatment options available through clinical trials is essential in order to achieve the best outcome from liver cancer treatment.
The Cancer Consultants Liver Cancer Information Center has been designed to help patients understand options for liver cancer prevention, early detection, and treatment, while providing ongoing information, inspiration, support, and community to individuals affected by a diagnosis of liver cancer.
Headline Liver Cancer News 
Approximately 16% of Worldwide Cancers Caused By Preventable Infections
About 16% of cancers worldwide are the result of preventable and treatable infections.
Oncology Experts Talk About Surgery, Ablation, Embolization, Radiation Therapy, Chemotherapy, and Clinical Trials for Primary Hepatocellular Carcinoma (Liver Cancer)
In a recent Web Chat on CancerConnect.com, Dr. Boris Kuvshinoff II and Dr. Renuka...
Aspirin Continues to Look Promising for Cancer Prevention
Study reports fewer cases and fewer deaths with daily use.
Liver Cancer Tips
Men, Fertility, and Cancer Men who confront a cancer diagnosis before beginning or completing their families...
Women, Fertility and Cancer Women who confront a cancer diagnosis before beginning or completing their families...
What is Genomics? You’ve probably heard of genetic testing for cancer susceptibility, but the more...
Liver Cancer Management
Inspiration, Hope & Resources
Jack & Jill Late Stage Cancer Foundation Jon Albert, founder of the Jack & Jill Late Stage Cancer Foundation shows the...
Moving Bodies, Changing Lives Moving On Aerobics helps women regain joy of movement and physical fitness after...
Where Kids Can Be Kids… And Cancer Takes a Back Seat Cancer camps for kids provide fun and camaraderie for children facing down a cancer...
Liver Cancer Clinical Trials
COGAEPI04C1 – Low Birth Weight & Other Risk Factors for Hepatoblastoma- A Groupwide Protocol
INSTOX-05-024 – Phase II Trial of Gemcitabine and Oxaliplatin (Gem-Ox) with Erlotinib (Tarceva) in the Treatment of Hepatocellular Carcinoma (HCC) in patients with adequate platelets (>100,000/?L)
ZX101-301 – A Phase II Randomized Controlled Study Comparing The Survival of Patients With Unresectable Hepatocellular Carcinoma (HCC) Treated With THYMITAQ To Patients Treated With Doxorubicin
 |
 |
 |
 |
